4//SEC Filing
WELTZIEN LOURDES 4
Accession 0001127602-21-028580
CIK 0000794172other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:12 PM ET
Size
7.0 KB
Accession
0001127602-21-028580
Insider Transaction Report
Form 4
WELTZIEN LOURDES
EVP, Life Science
Transactions
- Award
Stock Options (Right to Buy)
2021-11-04+11,669→ 11,669 totalExercise: $18.88Exp: 2031-11-04→ Common Stock (11,669 underlying) - Award
Common Stock
2021-11-04+10,593→ 87,637 total
Footnotes (2)
- [F1]These restricted stock units are awarded under the 2021 Omnibus Award Plan and vest in four equal installments from the date of grant (i.e., vest 25% per year until fully vested on November 4, 2025).
- [F2]These non-qualified options are awarded under the 2021 Omnibus Award Plan and vest as follows: (i) 25% of the options awarded vest on November 4, 2022; and (ii) the remaining 75% of the options awarded vest pro rata each month from November 4, 2022 through November 4, 2025.
Documents
Issuer
MERIDIAN BIOSCIENCE INC
CIK 0000794172
Entity typeother
Related Parties
1- filerCIK 0001201184
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:12 PM ET
- Size
- 7.0 KB